Bococizumab: Phase III data

Top-line data from the double-blind, international Phase III SPIRE- FH trial in 370 patients with HeFH at high or very high risk of

Read the full 233 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE